This comprehensive review breaks down Bio Protocol’s mission to tokenize biotech research through a decentralised launchpad, veBIO staking mechanics and on-chain BioAgents. We analyse the product stack, tokenomics, roadmap, community traction and key risks (regulatory, attestation, mint-role centralisation). Updated to August 2025.
Free Membership Required
You must be a Free member to access this content.
Already a member? Log in here